Apogee Therapeutics, Inc.

Nuveen, LLC APGE
Report date
12/31/2025
Quarter
2025 Q4
Filed
2/12/2026
Shares
121,050
Value ($000)
9,137
Weight
0.0%
2025 Q1 - 2025 Q4 (4 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).